Stock GPCR STRUCTURE THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Structure Therapeutics Inc.

Equities

GPCR

US86366E1064

Market Closed - Nasdaq
Other stock markets
 01:30:00 04/06/2024 am IST 		Pre-market 06:04:10 pm
52.74 USD +54.21% Intraday chart for Structure Therapeutics Inc. 56.75 +7.60%
03/06 Structure Therapeutics Plans Offering of American Depositary Shares MT
03/06 Top Midday Gainers MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Structure Therapeutics Plans Offering of American Depositary Shares
MT
Structure Therapeutics Announces Proposed Public Offering of American Depositary Shares and Pre-Funded Warrants
GL
Top Midday Gainers
MT
Sector Update: Health Care Stocks Edge Higher Monday Afternoon
MT
Structure Therapeutics Reports Positive Topline Data From Obesity Trial; Shares Jump
MT
Structure Therapeutics' obesity drug meets main goal in mid-stage study
RE
Structure Therapeutics Reports Positive Topline Data from its Phase 2a Obesity Study and Capsule to Tablet PK Study for its Oral Non-Peptide Small Molecule GLP-1 Receptor Agonist GSBR-1290
GL
Structure Therapeutics Inc. Reports Positive Topline Data from its Phase 2a Obesity Study and Capsule to Tablet PK Study for its Oral Non-Peptide Small Molecule GLP-1 Receptor Agonist GSBR-1290
CI
Structure Therapeutics Inc. Announces Ramy Farid Not Standing for Re-Election to Board of Directors, Term Expire on June 25, 2024
CI
JPMorgan Starts Structure Therapeutics With Overweight Rating
MT
Structure Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights
GL
Cantor Fitzgerald Initiates Structure Therapeutics at Overweight Rating With $65 Price Target
MT
ADRs Edge Higher; Lufax Climbs Almost 46%
DJ
Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference
AQ
Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference
GL
Structure Therapeutics Q4 Loss Widens
MT
Structure Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Structure Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GPCR Stock
  4. News Structure Therapeutics Inc.